L-Carnosine and Reduced Psychopathology Symptoms

Doses used in studies

Time to effect

Median: 3 months · IQR 3 months–3 months · Range 3 months–3 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityIncreased risk30% vs 14%
The carnosine group reported more adverse events (30%) compared with the placebo group (14%).
from: A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improv
laboratory indicesReported
Laboratory indices remained within acceptable ranges.
from: A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improv

1 of 1 paper

A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia.